Diatrizoate meglumine is a type of contrast agent used in medical imaging procedures to improve the clarity of X-rays, computed tomography (CT) scans, and angiography. It contains iodine, which makes it visible on imaging scans. When injected into the body or ingested orally, diatrizoate meglumine helps enhance the visibility of blood vessels, organs, and tissues in the resulting images. This enhancement aids healthcare professionals in diagnosing various medical conditions, including vascular diseases, tumors, and organ abnormalities. After the imaging procedure, diatrizoate meglumine is eliminated from the body, primarily through the kidneys. It’s important to be aware that diatrizoate meglumine may cause side effects or allergic reactions, although these are uncommon. Common side effects may include temporary flushing, warmth, or a metallic taste in the mouth, while serious allergic reactions may include difficulty breathing or swelling of the face or throat. Patients undergoing imaging procedures with diatrizoate meglumine should be closely monitored by healthcare professionals for any signs of adverse reactions. Individuals with a history of allergies, asthma, or kidney problems should inform their healthcare provider before receiving diatrizoate meglumine.